TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes

<p>Abstract</p> <p>Background</p> <p>Obesity is one of the most important medical and public health problems of our time: it increases the risk of many health complications such as hypertension, coronary heart disease and type 2 diabetes, needs long-lasting treatment fo...

Full description

Bibliographic Details
Main Authors: Tuzzi Cristina, Cesa Gian, Cuzziol Paola, Manzoni Gian, Castelnuovo Gianluca, Villa Valentina, Liuzzi Antonio, Petroni Maria, Molinari Enrico
Format: Article
Language:English
Published: BMC 2010-04-01
Series:BMC Public Health
Online Access:http://www.biomedcentral.com/1471-2458/10/204
_version_ 1811285770165551104
author Tuzzi Cristina
Cesa Gian
Cuzziol Paola
Manzoni Gian
Castelnuovo Gianluca
Villa Valentina
Liuzzi Antonio
Petroni Maria
Molinari Enrico
author_facet Tuzzi Cristina
Cesa Gian
Cuzziol Paola
Manzoni Gian
Castelnuovo Gianluca
Villa Valentina
Liuzzi Antonio
Petroni Maria
Molinari Enrico
author_sort Tuzzi Cristina
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Obesity is one of the most important medical and public health problems of our time: it increases the risk of many health complications such as hypertension, coronary heart disease and type 2 diabetes, needs long-lasting treatment for effective results and involves high public and private costs. Therefore, it is imperative that enduring and low-cost clinical programs for obesity and related co-morbidities are developed and evaluated.</p> <p>Methods/Design</p> <p>TECNOB (TEChnology for OBesity) is a comprehensive two-phase stepped down program enhanced by telemedicine for the long-term treatment of obese people with type 2 diabetes seeking intervention for weight loss. Its core features are the hospital-based intensive treatment (1-month), that consists of diet therapy, physical training and psychological counseling, and the continuity of care at home using new information and communication technologies (ICT) such as internet and mobile phones. The effectiveness of the TECNOB program compared with usual care (hospital-based treatment only) will be evaluated in a randomized controlled trial (RCT) with a 12-month follow-up. The primary outcome is weight in kilograms. Secondary outcome measures are energy expenditure measured using an electronic armband, glycated hemoglobin, binge eating, self-efficacy in eating and weight control, body satisfaction, healthy habit formation, disordered eating-related behaviors and cognitions, psychopathological symptoms and weight-related quality of life. Furthermore, the study will explore what behavioral and psychological variables are predictive of treatment success among those we have considered.</p> <p>Discussion</p> <p>The TECNOB study aims to inform the evidence-based knowledge of how telemedicine may enhance the effectiveness of clinical interventions for weight loss and related type-2 diabetes, and which type of obese patients may benefit the most from such interventions. Broadly, the study aims also to have a effect on the theoretical model behind the traditional health care service, in favor of a change towards a new "health care everywhere" approach.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN07265661</p>
first_indexed 2024-04-13T02:48:56Z
format Article
id doaj.art-ce7d1867a1454d0e80df6faa93cd7c4c
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-04-13T02:48:56Z
publishDate 2010-04-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-ce7d1867a1454d0e80df6faa93cd7c4c2022-12-22T03:05:54ZengBMCBMC Public Health1471-24582010-04-0110120410.1186/1471-2458-10-204TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetesTuzzi CristinaCesa GianCuzziol PaolaManzoni GianCastelnuovo GianlucaVilla ValentinaLiuzzi AntonioPetroni MariaMolinari Enrico<p>Abstract</p> <p>Background</p> <p>Obesity is one of the most important medical and public health problems of our time: it increases the risk of many health complications such as hypertension, coronary heart disease and type 2 diabetes, needs long-lasting treatment for effective results and involves high public and private costs. Therefore, it is imperative that enduring and low-cost clinical programs for obesity and related co-morbidities are developed and evaluated.</p> <p>Methods/Design</p> <p>TECNOB (TEChnology for OBesity) is a comprehensive two-phase stepped down program enhanced by telemedicine for the long-term treatment of obese people with type 2 diabetes seeking intervention for weight loss. Its core features are the hospital-based intensive treatment (1-month), that consists of diet therapy, physical training and psychological counseling, and the continuity of care at home using new information and communication technologies (ICT) such as internet and mobile phones. The effectiveness of the TECNOB program compared with usual care (hospital-based treatment only) will be evaluated in a randomized controlled trial (RCT) with a 12-month follow-up. The primary outcome is weight in kilograms. Secondary outcome measures are energy expenditure measured using an electronic armband, glycated hemoglobin, binge eating, self-efficacy in eating and weight control, body satisfaction, healthy habit formation, disordered eating-related behaviors and cognitions, psychopathological symptoms and weight-related quality of life. Furthermore, the study will explore what behavioral and psychological variables are predictive of treatment success among those we have considered.</p> <p>Discussion</p> <p>The TECNOB study aims to inform the evidence-based knowledge of how telemedicine may enhance the effectiveness of clinical interventions for weight loss and related type-2 diabetes, and which type of obese patients may benefit the most from such interventions. Broadly, the study aims also to have a effect on the theoretical model behind the traditional health care service, in favor of a change towards a new "health care everywhere" approach.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN07265661</p>http://www.biomedcentral.com/1471-2458/10/204
spellingShingle Tuzzi Cristina
Cesa Gian
Cuzziol Paola
Manzoni Gian
Castelnuovo Gianluca
Villa Valentina
Liuzzi Antonio
Petroni Maria
Molinari Enrico
TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes
BMC Public Health
title TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes
title_full TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes
title_fullStr TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes
title_full_unstemmed TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes
title_short TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes
title_sort tecnob study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type 2 diabetes
url http://www.biomedcentral.com/1471-2458/10/204
work_keys_str_mv AT tuzzicristina tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT cesagian tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT cuzziolpaola tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT manzonigian tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT castelnuovogianluca tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT villavalentina tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT liuzziantonio tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT petronimaria tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes
AT molinarienrico tecnobstudydesignofarandomizedcontrolledtrialofamultidisciplinarytelecareinterventionforobesepatientswithtype2diabetes